Contact us (+ 7 (921) 446-25-10)
×
Texting is available for authorized users.
Please register or log in at the website.
×
Your request for online training has been sent. Cbonds managers will be in touch with you shortly. Thank you!

New bond issue: Teva Pharmaceutical Industries issued international bonds (XS1789456024) with a 4.5% coupon for EUR 900.0m maturing in 2025

March 09, 2018 | Cbonds

March 07, 2018 Teva Pharmaceutical Industries issued international bonds (XS1789456024) with a 4.5% for EUR 900.0m maturing in 2025. Bonds were sold at a price of 100%. Bookrunner: Barclays, BNP Paribas, Citigroup, Credit Suisse, HSBC, Bank of America Merrill Lynch. Depository: Clearstream Banking S.A., Euroclear Bank.

Issue: Teva Pharmaceutical Industries, 4.5% 1mar2025, EUR

StatusCountry of riskRedemption (offer)VolumeIssue Rating (M/S&P/F)
outstandingIsrael03/01/20252,200,000 EURBB/Ba2/BB

Company: Teva Pharmaceutical Industries

Full company nameTeva Pharmaceutical Industries Limited
Country of riskIsrael
Country of registrationIsrael
IndustryHealthсare

Share:

Similar news:
minimizeexpand
Cbonds is a global fixed income data platform
  • Cbonds is a global data platform on bond market
  • Coverage: more than 170 countries and 250,000 domestic and international bonds
  • Various ways to get data: descriptive data and bond prices - website, xls add-in, mobile app
  • Analytical functionality: bond market screener, Watchlist, market maps and other tools
×